Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis

NCT02737202 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Baylor College of Medicine

Collaborators